AlphaFold predicted structure
PI4K2A · Q9BTU6

Mean pLDDT
79.3/ 100
Confident
479 residues
Confidence breakdown
- Very high(≥ 90)55%
- Confident(70–90)17%
- Low(50–70)10%
- Very low(< 50)19%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
phosphatidylinositol 4-kinase type 2 alpha
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Early onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalneurodevelopmental disorder with hyperkinetic movements, seizures, and structural brain abnormalities
neurodegenerative disease
hypertensive disorder
lung cancer
colon adenocarcinoma
lung carcinoma
Young adult-onset Parkinsonism
amyotrophic lateral sclerosis
Hereditary late-onset Parkinson disease
behavioral variant of frontotemporal dementia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Phosphatidylinositol 4-kinase type 2-alpha
Membrane-bound phosphatidylinositol-4 kinase (PI4-kinase) that catalyzes the phosphorylation of phosphatidylinositol (PI) to phosphatidylinositol 4-phosphate (PI4P), a lipid that plays important roles in endocytosis, Golgi function, protein sorting and membrane trafficking and is required for prolonged survival of neurons. Besides, phosphorylation of phosphatidylinositol (PI) to phosphatidylinositol 4-phosphate (PI4P) is the first committed step in the generation of phosphatidylinositol 4,5-bisphosphate (PIP2), a precursor of the second messenger inositol 1,4,5-trisphosphate (InsP3)
PI4K2A · Q9BTU6

Mean pLDDT
79.3/ 100
Confident
479 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0